PD-L1 as the Prognostic Immune Biomarker for Predicting the Relapse of Locally Advanced Cervical Adenocarcinoma and Adenosquamous Carcinoma Treated With Definitive Chemoradiation Therapy

International Journal of Radiation Oncology Biology Physics - Netherlands
doi 10.1016/j.ijrobp.2017.06.1318

Related search